Delivery Order SPE2DB22D3011-SPE2DB25FQ2WU
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $35,435.40 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 9, 2025, for Zepbound 7.5 mg/0.5 mL pens. The contract, which carries an ultimate completion date of September 10, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,848.55 by the Defense Logistics Agency on August 27, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. The contract utilized firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 28, 2025, with the place of performance at the company's Conshohocken...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,812.90 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025, with completion scheduled for August 18, 2025. The contract covers the supply of Zepbound 5 mg/0.5 mL pen injections and represents a non-competitive, competitively awarded delivery order under the company's existing Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,054.70 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and requires completion by August 26, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,459.86 by the Defense Logistics Agency on September 15, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL). The contract is classified as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the company's location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $38,628.48 delivery order contract by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 27, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,040.82 by the Defense Logistics Agency (DLA) for Zepbound 5 mg/0.5 ml pens. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,761.00 for the supply of Zepbound 7.5 mg/0.5 ml pen injections under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive delivery order issued against the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for $43,155.50 (ceiling value) to supply Zepbound 15 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and was awarded competitively without a set-aside designation. The place of performance is the...